
Gena Foster MD (PhD candidate) (She/Her)
Hematologic Oncology
Assistant Professor of Medicine, Hematology
Join to view full profile
333 Cedar StRm WwwNew Haven, CT 06510
Phone+1 203-785-5196
Fax+1 203-785-4116
Dr. Foster is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gena Foster is a hematology specialist with a subspecialty in hematologic oncology based in New Haven, CT. She completed her fellowship in Hematology and Medical Oncology at Yale-New Haven Medical Center (2016-2019), after earning her medical degree from George Washington University School of Medicine and Health Sciences in 2013, and completing her internal medicine residency at Duke University Hospital (2013-2016). Dr. Foster has authored several publications in prominent journals such as Science, Nature Immunology, and Cell, with her works frequently cited by other researchers.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Duke University HospitalResidency, Internal Medicine, 2013 - 2016
George Washington University School of Medicine and Health SciencesClass of 2013
Certifications & Licensure
CT State Medical License 2016 - 2026
IL State Medical License 2023 - 2026
NC State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 43 citationsKLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection.Eric Fagerberg, John Attanasio, Christine Dien, Jaiveer Singh, Emily A Kessler
Science. 2025-01-02 - 359 citationsNeoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.Can Cui, Jiawei Wang, Eric Fagerberg, Ping-Min Chen, Kelli A. Connolly
Cell. 2021-11-30 - 19 citationsA mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma.Brittany Fitzgerald, Kelli A. Connolly, Can Cui, Eric Fagerberg, Dylan L. Mariuzza
Cell Reports Methods. 2021-09-27
Press Mentions
New ACR Guidance on VEXAS Describes Diagnosis, Management of Rare ConditionAugust 26th, 2025
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









